Prevention of depression in patients with acute coronary syndrome (DECARD) randomized trial: effects on and by self-reported health.

Carsten Rygaard HjorthøjBaiba Hedegaard HansenJamal Abed HanashAlice RasmussenMorten Birket-Smith

Published in: Early intervention in psychiatry (2014)

The SF-36 may be too broad an outcome measure in trials or treatments that seek to prevent depression following acute coronary syndrome. The SF-36 may, however, indicate who is more likely to benefit from treatment.

Keyphrases

acute coronary syndrome
depressive symptoms
sleep quality
healthcare
public health
mental health
antiplatelet therapy
health information
coronary artery disease
social media
atrial fibrillation